Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca image

AstraZeneca to pay up to $1.2 billion for Pearl

June 10, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics

AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …

News
astrazeneca image

AstraZeneca abandons late-stage RA drug

June 5, 2013
Research and Development, Sales and Marketing AstraZeneca, RA, Rigel

AstraZeneca is to exit development of a new rheumatoid arthritis drug, after Phase III trials produced disappointing results.The Anglo-Swedish firm …

News
astrazeneca image

AstraZeneca/BMS drug granted speedy FDA review

June 5, 2013
Sales and Marketing AstraZeneca, BMS, lipodystrophy

AstraZeneca and partner Bristol-Myers Squibb have been granted a priority review for their rare disease drug metreleptin. The medicine is …

News
AstraZeneca image

AstraZeneca and CRUK partner on drug trial

May 31, 2013
Sales and Marketing AstraZeneca, CRUK

AstraZeneca is partnering with Cancer Research UK to develop a new oncology medicine that targets a number of different cancers. …

News
astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013
Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

News
astrazeneca image

AstraZeneca signs $200m nanomedicine deal

April 23, 2013
Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine

AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …

News

Oxford Cancer Biomarkers signs discovery deal with AstraZeneca

April 18, 2013
Research and Development AstraZeneca, Oxford Cancer Biomarkers

AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …

News

MedImmune buys AlphaCore

April 9, 2013
Research and Development AlphaCore, AstraZeneca, MedImmune

AstraZeneca’s biologics R&D arm MedImmune has bought private US biotech firm AlphaCore Pharma for an undisclosed sum.The acquisition is part …

News
crestor image

AstraZeneca settles Crestor case

March 26, 2013
Sales and Marketing AstraZeneca, Crestor, Watson

AstraZeneca has settled a long-running legal battle over one of its biggest brands, Crestor, whose patent expires in 2016. The …

News

AstraZeneca hires strategy boss

March 25, 2013
Sales and Marketing AstraZeneca, dunoyer

AstraZeneca has poached one of GlaxoSmithKline’s senior executives to help push through its new growth strategy. Marc Dunoyer, global head …

News
Astrazeneca image

AstraZeneca sets out growth strategy

March 21, 2013
Sales and Marketing AstraZeneca, R&D

AstraZeneca has set out an ambitious plan designed to return it to growth which eschews diversification and sets great store …

News
Astrazeneca image

AstraZeneca restructures global R&D

March 19, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D

AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …

News
Forxiga image

NICE rejects Forxiga

February 1, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes

NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …

News
Astrazeneca image

AstraZeneca signs respiratory deal

January 29, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory

AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …

News
Astrazeneca image

AstraZeneca shakes up management

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot

AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025